Target intelligence / Profile preview

GC-rich sequence DNA-binding factor 2 (GCFC2)

Target
GCFC2
Molecular classification
Transcription-associated factor (non-canonical; annotation disputed due to early chimera artifact), RNA splicing regulator, Other: Gene with protein product
01

Overview

GC-rich sequence DNA-binding factor 2 is a protein encoded by the human GCFC2 gene. Early research mistakenly identified it as a transcription factor involved in binding GC-rich DNA, based on an artificial chimera transcript. Later analyses refined its function, showing it is involved in the regulation of pre-mRNA splicing, specifically the spliceosome C complex, and may participate in turnover of excised introns. It has limited clinical association, mainly with dyslexia and reading disorders, but is not currently considered a druggable or therapeutic target. The initial molecular annotation is recognized as contentious, and its canonical function should be considered related to RNA processing rather than DNA transcription regulation. The name and historical functional annotation ("GC-rich sequence DNA-binding factor 2" as a DNA-binding transcription factor) are misleading. The actual primary function supported by current molecular data is RNA splicing regulation, not DNA binding or transcription factor activity.

Other names
GCFC2C2orf3DNABFGCFTCF9
02

Mechanism of action

None applicable, as no drugs target this molecule.

03

Biological functions

Pre-mRNA splicing, specifically regulating spliceosome C complex formationTurnover of excised intronsWeak/dubious association with DNA-binding/transcription repression due to labeling error in original annotation
04

Disease associations

DyslexiaReading disorderLimited evidence of additional disease associations; literature is sparse and there are no well-established links to major disorders such as cancer, inflammation, etc.

Beyond the preview

Go deeper on GC-rich sequence DNA-binding factor 2 (GCFC2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GC-rich sequence DNA-binding factor 2 (GCFC2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call